AKTX vs FTV · $17.2M cap vs P/E 31, rev $6.23B
Akari Therapeutics PLC (AKTX) versus Fortive Corp (FTV) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
Fortive Corp (FTV) is a scientific & technical instruments company listed on US.
AKTX does not have a complete income-statement cache yet.
Latest reported FTV revenue for 2024-12-31 was $6.23B. Net income was $832.9M. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
AKTX currently screens at market cap $17.2M. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
Not investment advice. Open the AKTX and FTV stock pages for the full models.
Not investment advice.